0001144204-18-000667.txt : 20180103 0001144204-18-000667.hdr.sgml : 20180103 20180103212948 ACCESSION NUMBER: 0001144204-18-000667 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180101 FILED AS OF DATE: 20180103 DATE AS OF CHANGE: 20180103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GIRSCHWEILER THOMAS CENTRAL INDEX KEY: 0001273547 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36362 FILM NUMBER: 18508297 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Taurus4757 GmbH CENTRAL INDEX KEY: 0001603397 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36362 FILM NUMBER: 18508296 BUSINESS ADDRESS: STREET 1: WISSMANNSTRASSE 15 CITY: ZURICH STATE: V8 ZIP: CH 8057 BUSINESS PHONE: 414 43620406 MAIL ADDRESS: STREET 1: WISSMANNSTRASSE 15 CITY: ZURICH STATE: V8 ZIP: CH 8057 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC CENTRAL INDEX KEY: 0000834365 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 943076866 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3303 MONTE VILLA PARKWAY STREET 2: SUITE 310 CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4254011400 MAIL ADDRESS: STREET 1: 3303 MONTE VILLA PARKWAY STREET 2: SUITE 310 CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: BIOLIFE SOLUTION INC DATE OF NAME CHANGE: 20030113 FORMER COMPANY: FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC DATE OF NAME CHANGE: 19920703 4 1 tv482648_4.xml OWNERSHIP DOCUMENT X0306 4 2018-01-01 0 0000834365 BIOLIFE SOLUTIONS INC BLFS 0001273547 GIRSCHWEILER THOMAS C/O BIOLIFE SOLUTIONS, INC. 3303 MONTE VILLA PARKWAY, SUITE 310 BOTHELL WA 98021 1 0 1 0 0001603397 Taurus4757 GmbH ROOSSTRASSE 53 CH-8832 WOLLERAU ZURICH V8 CH 8057 SWITZERLAND 0 0 1 0 Common Stock 2018-01-01 4 A 0 10000 A 2823843 I By Taurus Common Stock 2018-01-03 4 A 0 834 A 2824677 I By Taurus The restricted stock was granted to Taurus4757 GmbH ("Taurus"), a wholly owned entity of the reporting person, pursuant to the BioLife Solutions 2013 Performance Incentive Plan and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The shares of common stock were issued to Taurus pursuant to the BioLife Solutions 2013 Performance Incentive Plan in lieu of the reporting person receiving $5,000 of director fees for the quarter at a price per share based upon the closing stock price of the issuer's common stock on the last day of the quarter. /s/ Roderick de Greef, as attorney-in-fact for Thomas Girschweiler and Tauras4757 GmbH 2018-01-03